Published in Immunology on March 01, 2002
Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns. Am J Respir Crit Care Med (2010) 2.64
Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles. J Immunol (2008) 2.27
T cell-mediated immune responses in human newborns: ready to learn? Clin Exp Immunol (2005) 1.50
Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response. Vaccine (2009) 1.45
Immune biology of macaque lymphocyte populations during mycobacterial infection. Clin Exp Immunol (2003) 1.20
Mycobacterial antigen-induced T helper type 1 (Th1) and Th2 reactivity of peripheral blood mononuclear cells from diabetic and non-diabetic tuberculosis patients and Mycobacterium bovis bacilli Calmette-Guérin (BCG)-vaccinated healthy subjects. Clin Exp Immunol (2009) 1.14
Novel human in vitro system for evaluating antimycobacterial vaccines. Infect Immun (2004) 1.10
Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults. Clin Vaccine Immunol (2015) 1.10
The influence of BCG vaccine strain on mycobacteria-specific and non-specific immune responses in a prospective cohort of infants in Uganda. Vaccine (2012) 1.08
Vaccine platform for prevention of tuberculosis and mother-to-child transmission of human immunodeficiency virus type 1 through breastfeeding. J Virol (2007) 1.04
Human immunodeficiency virus (HIV) infection during pregnancy induces CD4 T-cell differentiation and modulates responses to Bacille Calmette-Guérin (BCG) vaccine in HIV-uninfected infants. Immunology (2009) 0.99
Safety and immunogenicity of novel recombinant BCG and modified vaccinia virus Ankara vaccines in neonate rhesus macaques. J Virol (2010) 0.99
Exposure of cord blood to Mycobacterium bovis BCG induces an innate response but not a T-cell cytokine response. Clin Vaccine Immunol (2008) 0.97
CD8+ regulatory T cells, and not CD4+ T cells, dominate suppressive phenotype and function after in vitro live Mycobacterium bovis-BCG activation of human cells. PLoS One (2014) 0.93
Dose-dependent immune response to Mycobacterium bovis BCG vaccination in neonates. Clin Vaccine Immunol (2006) 0.90
A comparative analysis of polyfunctional T cells and secreted cytokines induced by Bacille Calmette-Guérin immunisation in children and adults. PLoS One (2012) 0.89
Regulatory T-Cells at the Interface between Human Host and Pathogens in Infectious Diseases and Vaccination. Front Immunol (2015) 0.89
A second-generation anti TB vaccine is long overdue. Ann Clin Microbiol Antimicrob (2004) 0.85
The contribution of non-conventional T cells and NK cells in the mycobacterial-specific IFNγ response in Bacille Calmette-Guérin (BCG)-immunized infants. PLoS One (2013) 0.84
Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis? Vaccine (2015) 0.82
Age-related waning of in vitro Interferon-gamma levels against r32kDaBCG in BCG vaccinated children. J Immune Based Ther Vaccines (2007) 0.81
High rate of Quantiferon positive and tuberculin negative tests in infants born at a large Italian university hospital in 2011: a cautionary hypothesis. Pathog Glob Health (2012) 0.81
Induction of granulysin and perforin cytolytic mediator expression in 10-week-old infants vaccinated with BCG at birth. Clin Dev Immunol (2010) 0.80
Immunogenicity of BCG in HIV-exposed and non-exposed infants following routine birth or delayed vaccination. Int J Tuberc Lung Dis (2015) 0.80
A Model to Explain How the Bacille Calmette Guérin (BCG) Vaccine Drives Interleukin-12 Production in Neonates. PLoS One (2016) 0.79
Investigating the non-specific effects of BCG vaccination on the innate immune system in Ugandan neonates: study protocol for a randomised controlled trial. Trials (2015) 0.78
The Current Status of BCG Vaccination in Young Children in South Korea. Tuberc Respir Dis (Seoul) (2012) 0.78
Immune Responses to Bacillus Calmette-Guérin Vaccination: Why Do They Fail to Protect against Mycobacterium tuberculosis? Front Immunol (2017) 0.75
Age at Mycobacterium bovis BCG Priming Has Limited Impact on Anti-Tuberculosis Immunity Boosted by Respiratory Mucosal AdHu5Ag85A Immunization in a Murine Model. PLoS One (2015) 0.75
Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B. Vaccine (2016) 0.75
Minimal Sex-Differential Modulation of Reactivity to Pathogens and Toll-Like Receptor Ligands following Infant Bacillus Calmette-Guérin Russia Vaccination. Front Immunol (2017) 0.75
Early life allergen and air pollutant exposures alter longitudinal blood immune profiles in infant rhesus monkeys. Toxicol Appl Pharmacol (2017) 0.75
Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science (1999) 17.48
Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA (1994) 14.96
Tolerance, danger, and the extended family. Annu Rev Immunol (1994) 14.94
Variation in protection by BCG: implications of and for heterologous immunity. Lancet (1995) 9.66
Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ (1994) 6.11
Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science (1996) 5.31
Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (1998) 3.59
Differential effects of cytolytic T cell subsets on intracellular infection. Science (1997) 3.39
Therapy of tuberculosis in mice by DNA vaccination. Nature (1999) 2.99
Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guérin vaccination. J Immunol (1999) 2.94
Interleukin-10. Curr Opin Immunol (1992) 2.85
Defining the requirements for immunological control of mycobacterial infections. Trends Microbiol (1999) 2.66
The host immune response to tuberculosis. Am J Respir Crit Care Med (1998) 2.35
Helminth- and Bacillus Calmette-Guérin-induced immunity in children sensitized in utero to filariasis and schistosomiasis. J Immunol (1999) 2.25
T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J Immunol (1997) 2.18
Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. J Infect Dis (2000) 2.08
Adjuvant modulation of immune responses to tuberculosis subunit vaccines. Infect Immun (1997) 2.05
CD4(+) T cell clones producing both interferon-gamma and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients. Clin Immunol (1999) 2.01
Increased antimycobacterial immunity in interleukin-10-deficient mice. Infect Immun (1999) 1.95
Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route. Infect Immun (1998) 1.85
Can eradication of helminthic infections change the face of AIDS and tuberculosis? Immunol Today (1999) 1.72
Human T cell responses induced by vaccination with Mycobacterium bovis bacillus Calmette-Guérin. J Immunol (1997) 1.64
CD8+ CTL from lungs of Mycobacterium tuberculosis-infected mice express perforin in vivo and lyse infected macrophages. J Immunol (2000) 1.61
Characterization of human Mycobacterium bovis bacille Calmette-Guérin-reactive CD8+ T cells. Infect Immun (1999) 1.60
Administration of the BCG vaccination using the multipuncture method in schoolchildren: a comparison with the intradermal method. Thorax (1999) 1.54
Relative contribution of interferon-gamma and interleukin-10 to resistance to murine African trypanosomosis. J Infect Dis (2001) 1.46
Correlates of protective immunity to Mycobacterium tuberculosis in humans. Clin Infect Dis (2000) 1.46
IL-10 converts human dendritic cells into macrophage-like cells with increased antibacterial activity against virulent Mycobacterium tuberculosis. J Immunol (2000) 1.42
Mycobacteria induce CD4+ T cells that are cytotoxic and display Th1-like cytokine secretion profile: heterogeneity in cytotoxic activity and cytokine secretion levels. Eur J Immunol (1993) 1.26
IL-10 exerts suppressive and enhancing effects on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J Immunol (1997) 1.24
Diurnal rhythmicity of human cytokine production: a dynamic disequilibrium in T helper cell type 1/T helper cell type 2 balance? J Immunol (1997) 1.23
Comparative genomics of the mycobacteria. Int J Med Microbiol (2000) 1.22
Induction of antigen-specific CD4+ HLA-DR-restricted cytotoxic T lymphocytes as well as nonspecific nonrestricted killer cells by the recombinant mycobacterial 65-kDa heat-shock protein. Eur J Immunol (1990) 1.18
Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease. Diabetes (1997) 1.13
BCG and tuberculosis. Arch Dis Child (1999) 1.11
IL-10 is required for development of protective Th1 responses in IL-12-deficient mice upon Candida albicans infection. J Immunol (1998) 1.09
Evidence for in vivo generation of cytotoxic T cells. PPD-stimulated lymphocytes from tuberculous pleural effusions demonstrate enhanced cytotoxicity with accelerated kinetics of induction. Am Rev Respir Dis (1992) 1.07
Teetering on the brink of danger. Science (1996) 1.05
Host genetic susceptibility to human tuberculosis. Novartis Found Symp (1998) 1.03
Decline in total serum IgE after treatment for tuberculosis. Lancet (1999) 1.00
Vaccines, genes and trials. Novartis Found Symp (1998) 1.00
Are CD4+ Th1 cells pro-inflammatory or anti-inflammatory? The ratio of IL-10 to IFN-gamma or IL-2 determines their function. Int Immunol (1995) 0.99
Cytokine-based human whole blood assay for the detection of antigen-reactive T cells. J Immunol Methods (1995) 0.98
Decreased interleukin-10 production by neonatal monocytes and T cells: relationship to decreased production and expression of tumor necrosis factor-alpha and its receptors. Pediatr Res (1996) 0.98
Can cord blood cells support the cytokine storm in GvHD? Cytokine Growth Factor Rev (2000) 0.95
Cellular immune responses to four doses of percutaneous bacille Calmette-Guérin in healthy adults. J Infect Dis (1998) 0.91
Generation of cytolytic T cells in individuals infected by Mycobacterium tuberculosis and vaccinated with BCG. Thorax (1992) 0.89
Comparative genomics and host resistance against infectious diseases. Emerg Infect Dis (1999) 0.87
New tuberculosis vaccines based on attenuated strains of the Mycobacterium tuberculosis complex. Immunol Cell Biol (2000) 0.87
Cytotoxic T cell responses to intracellular pathogens. Curr Opin Immunol (1998) 0.86
Differential development of type 1 and type 2 cytokines and beta-chemokines in the ontogeny of healthy newborns. Biol Neonate (1999) 0.85
Vaccine immunity. Immunol Today (1997) 0.83
A longitudinal study of in vitro IFNgamma production and cytotoxic T cell responses of tuberculosis patients in the gambia. Tuber Lung Dis (2000) 0.80
Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns. Am J Respir Crit Care Med (2010) 2.64
The effect of bacille Calmette-Guérin vaccine strain and route of administration on induced immune responses in vaccinated infants. J Infect Dis (2006) 1.64
The impact of a change in bacille Calmette-Guérin vaccine policy on tuberculosis incidence in children in Cape Town, South Africa. Pediatr Infect Dis J (2006) 0.99
Dose-dependent immune response to Mycobacterium bovis BCG vaccination in neonates. Clin Vaccine Immunol (2006) 0.90
Rifampin levels, interferon-gamma release and outcome in complicated pulmonary tuberculosis. Tuberculosis (Edinb) (2007) 0.86
Compositional requirements of follow-up formula for use in infancy: recommendations of an international expert group coordinated by the Early Nutrition Academy. Ann Nutr Metab (2012) 0.82
The utility of computed tomography for recent-onset partial seizures in childhood. S Afr Med J (2006) 0.79
Risk of Disease After Isoniazid Preventive Therapy for Mycobacterium tuberculosis Exposure in Young HIV-uninfected Children. Pediatr Infect Dis J (2015) 0.78
Endoscopic injection sclerotherapy for bleeding varices in children with intrahepatic and extrahepatic portal venous obstruction: benefit of injection tract embolisation. S Afr Med J (2012) 0.78